Cholinergic degeneration has been linked to the progression of clinical manifestations of AD in humans and experimental animal models, and AChE inhibitors have been widely used clinically to combat the symptoms cognitive impairment (Droguerre et al. 2020; Jiang et al. 2019; Sonkusare et al. 2005). The gene discussed is ACHE; the disease is Cognitive impairment.